Cellid Co., Ltd.

8 clinical trials · Sponsor

Record	Firm	Date
A Phase I/IIa Clinical Trial to Investigate BVAC-E6E7 in Subjects With HPV Positive HNSCC. (NCT06797986)	Cellid Co., Ltd.	2026-02-04
Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers (NCT05993325)	Cellid Co., Ltd.	2023-11-27
Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine (NCT05576623)	Cellid Co., Ltd.	2022-09-14
Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1 (NCT05520970)	Cellid Co., Ltd.	2022-08-19
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers (NCT05047692)	Cellid Co., Ltd.	2021-09-09
Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers (NCT04666012)	Cellid Co., Ltd.	2020-12-29
Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care (NCT03425773)	Cellid Co., Ltd.	2018-02-26

Every clearance here is in the API, with alerts when new ones post.